Literature DB >> 3983039

Controversies in the medical management of breast cancer.

I E Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3983039      PMCID: PMC2418174          DOI: 10.1136/pgmj.61.712.117

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  27 in total

1.  Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy.

Authors:  R T Chlebowski; L E Irwin; R P Pugh; L Sadoff; R Hestorff; J M Wiener; J R Bateman
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

2.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

3.  Screening for cancer.

Authors:  J Chamberlain
Journal:  Br J Hosp Med       Date:  1982-06

4.  The social, emotional and financial implications of adjuvant chemotherapy in breast cancer.

Authors:  C S McArdle; K C Calman; A F Cooper; A V Hughson; A R Russell; D C Smith
Journal:  Br J Surg       Date:  1981-04       Impact factor: 6.939

5.  Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy.

Authors:  G P Maguire; A Tait; M Brooke; C Thomas; J M Howat; R A Sellwood; H Bush
Journal:  Br Med J       Date:  1980-11-01

6.  Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.

Authors:  T Priestman; M Baum; V Jones; J Forbes
Journal:  Br Med J       Date:  1977-05-14

7.  Adjuvant chemotherapy for breast cancer: side effects and quality of life.

Authors:  B V Palmer; G A Walsh; J A McKinna; W P Greening
Journal:  Br Med J       Date:  1980-12-13

8.  The curability of breast cancer.

Authors:  D Brinkley; J L Haybrittle
Journal:  Lancet       Date:  1975-07-19       Impact factor: 79.321

9.  Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer.

Authors:  T J Powles; R C Coombes; I E Smith; J M Jones; H T Ford; J C Gazet
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

10.  Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research.

Authors:  F Cavalli; M Beer; G Martz; W F Jungi; P Alberto; J P Obrecht; B Mermillod; K W Brunner
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-01
View more
  3 in total

1.  Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study.

Authors:  M Gereis; A P Burford-Mason; S M Watkins
Journal:  Agents Actions       Date:  1987-12

Review 2.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

3.  How Effective is the Treatment of Locally Advanced and Metastatic Breast Cancer in Developing Centres?: A Retrospective Review.

Authors:  Agodirin Olayide; Olatoke Samuel; Rahman Ganiyu; Adeoti Moses; Oyeyemi Gafar; Durojaiye Abiola; Kolawole Dapo; Agboola John
Journal:  Ethiop J Health Sci       Date:  2015-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.